Pharmaceutical Supply and Payment Chain Coalition Announces Guiding Principles for Safe, Efficacious Access to COVID-19 Vaccine

Published: October 22, 2020
ASHP Press Release

Today, representative organizations of America’s pharmaceutical supply and payment chain, including prescription and over-the-counter brand and generic manufacturers; pharmacies and pharmacists across all practice settings, including health systems and hospitals, community, specialty, and managed care; supermarkets; wholesalers; pharmaceutical quality standard developers; employers and other health plan sponsors; health insurance providers; and pharmacy benefit managers, released guiding principles for the safe efficacious development, distribution, and allocation of vaccine(s) to achieve mass immunization against the coronavirus (COVID-19).

The guiding principles represent the commitment of the private sector to the efficient, well-coordinated distribution, allocation, and mass immunization against COVID-19 as a necessary countermeasure to the current pandemic.

Click here to read: Guiding Principles for Safe and Efficacious COVID-19 Vaccine Development, Distribution, Allocation, and Mass Immunization.

The strong and ongoing collaboration demonstrated by the pharmaceutical supply and payment chain has been essential for a host of issues important to Americans during the COVID-19 pandemic. The coalition looks forward to continuing to work together in the best interest of the individuals and families that we serve.

For additional information and resources on the individual efforts of each of these organizations, please see the links below.


Press Contacts: 

Posted October 22, 2020

Advance Your Professional Development

View Other Products

Free Board Exam Prep Resources

The Review & Recertification Reward Program (RRRP) includes free access to exam preparation material + enrollment in a recertification plan billed monthly ($10) during your initial recertification cycle. For ASHP members only.

Learn More
Review & Recertification Reward Program (RRRP)

New Edition Available to Order

AHFS Drug Information® 2024 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Order Today
AHFS 2024 Drug Information